Digital test plus blood biomarker boosts accuracy of Alzheimer’s diagnosis in primary care

Government

By Vijay Kumar Malesu Reviewed by Susha Cheriyedath, M.Sc. Oct 12 2025 By confirming cognitive impairment before ordering amyloid blood tests, this two-step approach cuts false positives, streamlines referrals, and moves Alzheimer’s diagnosis closer to everyday clinics. Study: Primary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers . Image Credit: Orawan Pattarawimonchai / Shutterstock In a recent study published in the journal  Nature

din zilele anterioare